Evidence map›Paper›PMID 25963161›Full record

ArticleBMC cancer2015

The patient-breast cancer care pathway: how could it be optimized?

Sandrine Baffert, Huong Ly Hoang, Anne Brédart, Bernard Asselain, Séverine Alran, Hélène Berseneff, Cyrille Huchon, Caroline Trichot, Aline Combes, Karine Alves and 5 more

Abstract read
In one paragraph

Article in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Observational
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sandrine BaffertDepartment of Health Economy, Institut Curie, 26 rue d'Ulm, 75005, Paris, France. sandrine.baffert@curie.fr.
Huong Ly HoangDepartment of Health Economy, Institut Curie, 26 rue d'Ulm, 75005, Paris, France. huongly.hoang@curie.fr.
Anne BrédartDepartment of Supportive Care, Institut Curie, 26 rue d'Ulm, 75005, Paris, France. anne.bredart@curie.fr.
Bernard AsselainDepartment of Biostatistics, Institut Curie, 26 rue d'Ulm, 75005, Paris, France. b.asselain@gmail.com.
Séverine AlranDepartment of Surgical Oncology, Institut Curie, 26 rue d'Ulm, 75005, Paris, France. severine.alran@curie.fr.
Hélène BerseneffDepartment of Gynecology, René Dubos Hospital, 6, avenue de L'Ile de France, 95303, Pontoise, France. helene.berseneff@ch-pontoise.fr.
Cyrille HuchonDepartment of Gynecology, Poissy-St Germain hospital, 10 Rue du Champ Gaillard, 78300, Poissy, France. cyrillehuchon@yahoo.fr.
Caroline TrichotDepartment of Gynecology, Antoine Béclère Hospital, 157 rue de la Porte de Trivaux, 92140, Clamart, France. caroline.trichot@abc.aphp.fr.
Aline CombesDepartment of Gynecology, André Mignot Hospital, 50 rue Berthier, 78000, Versailles, France. acombes@ch-versailles.fr.
Karine AlvesDepartment of Gynecology, Argenteuil Hospital, 69 Rue Lt Colonel Prudhon, 95100, Argenteuil, France. alveskarine22@yahoo.fr.
Martin KoskasDepartment of Gynecology, Bichat Hospital, 46 rue Henri Huchard, 75018, Paris, France. martin.koskas@wanadoo.fr.
Thuy NguyenDepartment of Gynecology, Louis Mourier Hospital, 178 rue des Renouillers, 92700, Colombes, France. thuy.nguyen@lmr.aphp.fr.
Aurélie RoulotDepartment of Surgical Oncology, Institut Curie-René Huguenin, 35 rue Dailly, 92210, St Cloud, France. aurelie.roulot@curie.fr.
Roman RouzierDepartment of Surgical Oncology, Institut Curie-René Huguenin, 35 rue Dailly, 92210, St Cloud, France. roman.rouzier@curie.fr.
Delphine HéquetDepartment of Surgical Oncology, Institut Curie-René Huguenin, 35 rue Dailly, 92210, St Cloud, France. delphine.hequet@curie.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA care pathway is defined as patient-focused global care that addresses temporal (effective and coordinated management throughout the illness) and spatial issues (treatment is provided near the health territory in or around the patient's home). Heterogeneity of the care pathways in breast cancer (BC) is presumed but not well evaluated. The OPTISOINS01 study aims to assess every aspect of the care pathway for early BC patients using a temporal and spatial scope. METHODS/

designAn observational, prospective, multicenter study in a regional health territory (Ile-de-France, France) in different types of structures: university or local hospitals and comprehensive cancer centers. We will include and follow during 1 year 1,000 patients. The study consists of 3 work-packages: - Cost of pathway The aim of this WP is to calculate the overall costs of the early BC pathway at 1 year from different perspectives (society, health insurance and patient) using a cost-of-illness analysis. Using a bottom-up method, we will assess direct costs, including medical direct costs and nonmedical direct costs (transportation, home modifications, home care services, and social services), and indirect costs (loss of production). - Patient satisfaction and work reintegration Three questionnaires will assess the patients' satisfaction and possible return to work: the occupational questionnaire for employed women; the questionnaire on the need for supportive care, SCNS-SF34 ('breast cancer' module, SCNS-BR8); and the OUTPASSAT-35 questionnaire. - Quality, coordination and access to innovation Quality will be evaluated based on visits and treatment within a set period, whether the setting offers a multidisciplinary consultative framework, the management by nurse coordinators, the use of a personalized care plan, the provision of information via documents about treatments and the provision of supportive care. The coordination between structures and caregivers will be evaluated at several levels. Day surgery, home hospitalization and one-stop breast clinic visits will be recorded to assess the patient's access to innovation. DISCUSSION: The assessment of care pathways encourages the implementation of new payment models. Our approach could help health care professionals and policymakers to establish other cost-of-illness studies and plan the allocation of resources on a patient basis rather than a visit basis.

Indexed as

Quality ImprovementBreast NeoplasmsCancer Care FacilitiesDisease ManagementFemaleHumansMulticenter Studies as TopicObservational Studies as TopicPatient CarePatient SatisfactionProspective StudiesQuality of LifeSurveys and Questionnaires

Identifiers

PMID25963161
PMCPMC4430872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.